1. Reitz, C.: Genetic diagnosis and prognosis of Alzheimer’s disease: challenges and opportunities. Expert Rev. Mol. Diagn. 15(3), 339–348 (2015)
2. Zhang, L., Fan, Z., Zhang, Z., et al.: Research progress in the pathogenesis of Alzheimer’s disease and related therapeutic drugs. Chin. J. Pharm. Chem. 31(06), 438–446+469 (2021)
3. Zhu, J., Zhang, Z., Dong, Y., Chen, N.: Research progress in Alzheimer’s disease and its therapeutic drugs. Chin. Pharmacol. Bull. 34(12), 1629–1634 (2018)
4. Zhong, F., Wang, L., Lai, H.: Clinical efficacy of memantine combined with donepezil in the treatment of elderly patients with moderate to severe Alzheimer’s disease. Contemp. Med. 28(14), 25–28 (2022)
5. Grossberg, G.T., Manes, F., Allegri, R.F., et al.: The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer’s disease taking cholinesterase inhibitors. CNS Drugs 27(6), 469–478 (2013)